Veracyte | VCYT - Operating Profit


Veracyte reported $23.11M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Agilent USD 443M 66M Sep/2025
Arrowhead Research USD 40.81M 3.3M Dec/2025
Bruker USD 83.9M 72M Sep/2025
Exact Sciences USD -25M 22.85M Sep/2025
Illumina USD 256M 6M Dec/2025
Laboratory Of America USD 397.3M 65.5M Sep/2025
Ligand Pharmaceuticals USD 158.89M 149.17M Sep/2025
Myriad Genetics USD -23.3M 10.8M Sep/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Siemens EUR 2.57B 189M Sep/2025
Sonic Healthcare AUD 435.76M 193.66M Dec/2024
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Veracyte USD 23.11M 8.8M Sep/2025
Waters USD 192.11M 3.9M Sep/2025